Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000507937 | SCV000604994 | likely benign | not specified | 2016-09-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000507937 | SCV003996283 | uncertain significance | not specified | 2023-04-17 | criteria provided, single submitter | clinical testing | The c.660C>G (p.S220R) alteration is located in exon 1 (coding exon 1) of the RAB40AL gene. This alteration results from a C to G substitution at nucleotide position 660, causing the serine (S) at amino acid position 220 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |